Who
Thomas B. Smith
EVP and Chief Medical Officer
Company insider
Files Form 4 as: EVP and Chief Medical Officer, Collegium Pharmaceutical; Chief Medical Officer, Biodelivery Sciences International.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $1.1M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Aug 2018
- Last trade
- 10 Feb 2026
- Last filed
- 12 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —14,268 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —22,774 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $276K5,897 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $539K11,538 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —14,268 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —22,774 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $276K5,897 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $539K11,538 at $46.75 | filing |
| 29 Aug 2025filed 3 Sep 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $672K17,478 at $38.42 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —33,762 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —5,313 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $46K1,498 at $30.52 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $134K4,399 at $30.52 | filing |
| 13 Sep 2024filed 17 Sep 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $351K9,593 at $36.62 | filing |
| 29 Feb 2024filed 4 Mar 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $37K995 at $36.76 | filing |
| 12 Feb 2024filed 14 Feb 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —30,800 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —4,623 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $64K1,899 at $33.70 | filing |
| 12 Feb 2024filed 14 Feb 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $44K1,300 at $33.70 | filing |
| 10 Feb 2023filed 14 Feb 2023 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —31,185 at $0.00 | filing |
News
Head to Head Survey: Collegium Pharmaceutical (NASDAQ:COLL) versus Journey Medical (NASDAQ:DERM)COLL · dailypolitical.com · 22 Oct 2026Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Thomas B. Smith; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.